Karyopharm Therapeutics

Price & Volume

Stats

See more
Open
$5.61
Previous Close
$5.90
Day Range
$5.51-$6.08
52W Range
$3.51-$16.95
Market Cap
$51.1M
Shares Short
2M

Financials

See more
Revenue (12 Mos)
$137.2M
Revenue Growth (YoY)
-11.4%
Gross Profit (12 Mos)
$138.6M
Diluted EPS
-$15.17

About

CEO
Mr. Richard A. Paulson M.B.A.
CFO
Ms. Lori A. Macomber CPA
Address
85 Wells Avenue, Newton, MA, United States, 02459-3298
Sector
Healthcare
Industry
Biotechnology
Full-Time Employees
279